Immunosuppressive drugs modes of action
The innate and adaptive immune systems work as a complex interplay between different cell types, involving cytokines and chemokines mediating extracellular and paracrine effects. At the intracellular level, the inflammatory cascade is mediated by multifaceted processes that have been better describe...
Saved in:
Published in | Baillière's best practice & research. Clinical gastroenterology Vol. 54-55; p. 101757 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
01.10.2021
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 1521-6918 1532-1916 1532-1916 |
DOI | 10.1016/j.bpg.2021.101757 |
Cover
Loading…
Abstract | The innate and adaptive immune systems work as a complex interplay between different cell types, involving cytokines and chemokines mediating extracellular and paracrine effects. At the intracellular level, the inflammatory cascade is mediated by multifaceted processes that have been better described in the last 10 years. Immunosuppressive agents available in clinical practice act at different points of those cascades at the intracellular or extracellular level. Those drugs can mediate their effects on one or more cell types finally limiting inflammation and immune responses to antigens. Every immunosuppressive agent is characterized by intrinsic toxicity and side effects that may be due to the same therapeutic pathways or to off-target secondary effect of each molecule. We will here review the mechanisms of action of the most widely used immunosuppressive agents in the field of solid organ transplantation and autoimmune disorders, describing the mechanisms underlying both the therapeutic and secondary effects. |
---|---|
AbstractList | The innate and adaptive immune systems work as a complex interplay between different cell types, involving cytokines and chemokines mediating extracellular and paracrine effects. At the intracellular level, the inflammatory cascade is mediated by multifaceted processes that have been better described in the last 10 years. Immunosuppressive agents available in clinical practice act at different points of those cascades at the intracellular or extracellular level. Those drugs can mediate their effects on one or more cell types finally limiting inflammation and immune responses to antigens. Every immunosuppressive agent is characterized by intrinsic toxicity and side effects that may be due to the same therapeutic pathways or to off-target secondary effect of each molecule. We will here review the mechanisms of action of the most widely used immunosuppressive agents in the field of solid organ transplantation and autoimmune disorders, describing the mechanisms underlying both the therapeutic and secondary effects. The innate and adaptive immune systems work as a complex interplay between different cell types, involving cytokines and chemokines mediating extracellular and paracrine effects. At the intracellular level, the inflammatory cascade is mediated by multifaceted processes that have been better described in the last 10 years. Immunosuppressive agents available in clinical practice act at different points of those cascades at the intracellular or extracellular level. Those drugs can mediate their effects on one or more cell types finally limiting inflammation and immune responses to antigens. Every immunosuppressive agent is characterized by intrinsic toxicity and side effects that may be due to the same therapeutic pathways or to off-target secondary effect of each molecule. We will here review the mechanisms of action of the most widely used immunosuppressive agents in the field of solid organ transplantation and autoimmune disorders, describing the mechanisms underlying both the therapeutic and secondary effects.The innate and adaptive immune systems work as a complex interplay between different cell types, involving cytokines and chemokines mediating extracellular and paracrine effects. At the intracellular level, the inflammatory cascade is mediated by multifaceted processes that have been better described in the last 10 years. Immunosuppressive agents available in clinical practice act at different points of those cascades at the intracellular or extracellular level. Those drugs can mediate their effects on one or more cell types finally limiting inflammation and immune responses to antigens. Every immunosuppressive agent is characterized by intrinsic toxicity and side effects that may be due to the same therapeutic pathways or to off-target secondary effect of each molecule. We will here review the mechanisms of action of the most widely used immunosuppressive agents in the field of solid organ transplantation and autoimmune disorders, describing the mechanisms underlying both the therapeutic and secondary effects. |
ArticleNumber | 101757 |
Author | Bestard, Oriol Meneghini, Maria Grinyo, Josep Maria |
Author_xml | – sequence: 1 givenname: Maria orcidid: 0000-0001-7307-923X surname: Meneghini fullname: Meneghini, Maria email: mmeneghini@vhebron.net organization: Nephrology and Kidney Transplantation Unit. Vall D’Hebron University Hospital, Barcelona. Spain – sequence: 2 givenname: Oriol surname: Bestard fullname: Bestard, Oriol email: obestard@vhebron.net organization: Nephrology and Kidney Transplantation Unit. Vall D’Hebron University Hospital, Barcelona. Spain – sequence: 3 givenname: Josep Maria surname: Grinyo fullname: Grinyo, Josep Maria email: jgrinyo@ub.edu organization: University of Barcelona. Department of Clinical Sciences. Barcelona. Spain |
BookMark | eNqFkM9LwzAUgINMcJv-Ad4GHvTS2Ze0TYMnGf4YDLzoOaTp60htm5q0g_33ttTTDvOUBL7vvfAtyKyxDRJyC-EaQkgey3XW7tc0pDC-ecwvyBxiRgMQkMzGO4UgEZBekYX3ZRgOkhBzcr-t676xvm9bh96bA65y1-_9qrY5-pUtVkp3xjbX5LJQlcebv3NJvl5fPjfvwe7jbbt53gU6iqELMhrmaQQcIcqVZumwVYFWOVMCokQXUZpzTjOWaCZ4lgCLMhARzwAp10zHbEkeprmtsz89-k7WxmusKtWg7b2kSZgCA07pgN6doKXtXTP8bqQ4gwSEGCiYKO2s9w4L2TpTK3eUEMoxnSzlkE6O6eSUbnD4iaNNp8YMnVOmOms-TSYOjQ4GnfTaYKMxNw51J3NrztrixNaVaYxW1Tce_3F_Ac5KmuQ |
CitedBy_id | crossref_primary_10_1186_s12876_025_03603_w crossref_primary_10_1038_s41598_025_90996_z crossref_primary_10_51847_BQ2peoCsFW crossref_primary_10_2217_frd_2023_0008 crossref_primary_10_3390_toxics12080607 crossref_primary_10_3389_fphar_2024_1397995 crossref_primary_10_3389_fimmu_2022_929995 crossref_primary_10_3390_ijms241210301 crossref_primary_10_1080_08820139_2024_2329203 crossref_primary_10_1007_s44368_024_00004_1 crossref_primary_10_61785_ael_199673 crossref_primary_10_1002_advs_202301777 crossref_primary_10_1097_MD_0000000000036483 crossref_primary_10_3389_fimmu_2024_1447337 crossref_primary_10_1007_s00101_023_01332_x crossref_primary_10_1080_17469899_2023_2296895 crossref_primary_10_1093_lambio_ovae047 crossref_primary_10_1007_s40011_023_01505_z crossref_primary_10_1080_2162402X_2024_2351255 crossref_primary_10_3897_pharmacia_70_e110353 crossref_primary_10_3389_fendo_2023_1226231 crossref_primary_10_1097_TXD_0000000000001666 crossref_primary_10_3390_ph18030342 crossref_primary_10_3390_ijms25084468 crossref_primary_10_3390_jcm12216955 crossref_primary_10_4274_tji_galenos_2024_84803 crossref_primary_10_1038_s41541_024_00886_0 |
Cites_doi | 10.1016/j.rdc.2015.08.002 10.1016/j.msard.2018.02.030 10.1016/j.dld.2006.10.017 10.1681/ASN.2017060679 10.1056/NEJMct1209614 10.2215/CJN.03791106 10.1358/dot.2009.45.7.1384878 10.1002/cpt.2220 10.1038/nrneph.2016.108 10.1097/TP.0b013e3181d02496 10.1097/01.tp.0000251975.81281.22 10.1385/MO:19:2S:S03 10.3389/fimmu.2018.02953 10.1038/s41575-020-0273-0 10.2165/0003495-200868170-00007 10.1002/cpt.546 10.1007/s11938-017-0128-0 10.1016/j.trre.2015.04.007 10.1136/ard.61.8.718 10.1038/srep34845 10.1111/ctr.12559 10.2217/fon.14.146 10.1097/MOT.0b013e32832b45d0 10.4161/mabs.22771 10.1097/00007890-200102150-00021 10.1016/j.transproceed.2009.08.043 10.2165/00003088-200746010-00002 10.4049/jimmunol.1390055 10.1016/j.trim.2012.11.008 10.1513/pats.200402-005MS 10.1053/j.ackd.2019.08.006 10.3389/fimmu.2021.661196 10.2147/ITT.S282466 10.1093/ndt/gfu079 10.2165/00063030-199809010-00004 10.1016/j.imbio.2009.10.003 10.1136/gutjnl-2018-317977 10.1056/NEJMoa021744 10.1172/JCI116440 10.1097/TP.0000000000000289 10.1016/S0162-3109(00)00188-0 10.1159/000127432 10.1111/j.1600-6143.2010.03400.x 10.1210/er.2002-0006 |
ContentType | Journal Article |
Copyright | 2021 The Authors 2021. The Authors Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. |
Copyright_xml | – notice: 2021 The Authors – notice: 2021. The Authors – notice: Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. |
DBID | 6I. AAFTH AAYXX CITATION K9. NAPCQ 7X8 |
DOI | 10.1016/j.bpg.2021.101757 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-1916 |
ExternalDocumentID | 10_1016_j_bpg_2021_101757 S1521691821000378 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CAG COF DU5 EBS EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OC. ON0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SEL SES SEW SSH SSZ SV3 T5K UHS WOW Z5R ~G- 6I. 7RV AACTN AAFTH AAIAV ABLVK ABYKQ AFKWA AJBFU AJOXV AMFUW AZQEC BENPR EFLBG LCYCR M0T M1P M2O RIG AAYXX AFCTW AGRNS CITATION K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c451t-b20d8417e14dac38521a1cad3a9146cf48d772b36c397b6134b1947b1e27c3c53 |
IEDL.DBID | .~1 |
ISSN | 1521-6918 1532-1916 |
IngestDate | Fri Jul 11 12:43:46 EDT 2025 Fri Jul 25 03:57:45 EDT 2025 Tue Jul 01 02:01:39 EDT 2025 Thu Apr 24 23:11:24 EDT 2025 Fri Feb 23 02:40:15 EST 2024 Tue Aug 26 16:58:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Autoimmunity Allotransplantation Immunosuppression |
Language | English |
License | This is an open access article under the CC BY license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c451t-b20d8417e14dac38521a1cad3a9146cf48d772b36c397b6134b1947b1e27c3c53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0001-7307-923X |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1521691821000378 |
PQID | 2607316199 |
PQPubID | 1226366 |
ParticipantIDs | proquest_miscellaneous_2608131722 proquest_journals_2607316199 crossref_primary_10_1016_j_bpg_2021_101757 crossref_citationtrail_10_1016_j_bpg_2021_101757 elsevier_sciencedirect_doi_10_1016_j_bpg_2021_101757 elsevier_clinicalkey_doi_10_1016_j_bpg_2021_101757 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October-December 2021 2021-10-00 20211001 |
PublicationDateYYYYMMDD | 2021-10-01 |
PublicationDate_xml | – month: 10 year: 2021 text: October-December 2021 |
PublicationDecade | 2020 |
PublicationPlace | Kidlington |
PublicationPlace_xml | – name: Kidlington |
PublicationTitle | Baillière's best practice & research. Clinical gastroenterology |
PublicationYear | 2021 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | Homan, Kolesky, Skylar-Scott, Herrmann, Obuobi, Moisan (bib18) 2016 Oct 11; 6 Han, Li, Ahn, Lim, Song, Jang (bib20) 2008 Sep; 28 Abulayha, Bredan, El Enshasy, Daniels (bib39) 2014; 10 Nielsen, Ainsworth (bib43) 2013 Aug 22; 369 Sanford, Keating (bib10) 2008; 68 Bhat, Watt (bib27) 2015 Jul 1; 29 Jefremow, Neurath (bib46) 2020 Nov; 9 Chakkera, Kudva, Kaplan (bib22) 2017; 101 Ashok kumar, Sun, Ningappa, Higgs, Mazariegos, Zeevi (bib28) 2015 Jan 15; 99 Cargill, Culver (bib41) 2021; 12 Préville, Flacher, LeMauff, Beauchard, Davelu, Tiollier (bib29) 2001 Feb 15; 71 Waldmann (bib37) 2002; 19 Schiff, Cole, Cantarovich (bib16) 2007; 2 Jordan, Toyoda, Kahwaji, Vo (bib33) 2011; 11 Leibler, Thiolat, Hénique, Samson, Pilon, Tamagne (bib34) 2018 Mar 10; 29 Kovarik, Mueller, Niese (bib15) 1996 Allison, Eugui (bib7) 2000; 47 Lanese, Conger (bib17) 1993; 91 Azzi, Sayegh, Mallat (bib12) 2013 Dec 15; 191 Dhesi, Boland, Colquhoun (bib38) 2009; 14 Buttgereit, Da Silva, Boers, Burmester, Cutolo, Jacobs (bib1) 2002; 61 Farouk, Rein (bib21) 2020 Jan 1; 27 Naujokat, Berges, Fuchs, Sadeghi, Opelz, Daniel (bib31) 2007 Feb; 83 Fantus, Rogers, Grahammer, Huber, Thomson (bib24) 2016; 12 Perez, Patel, Mardis, Meadows, Taber, Pilch (bib35) 2018; 102 Costantino, della Torre, Lo Presti, Caruso, Mazzon, Fries (bib44) 2008 Jan; 40 Anstey, Lear (bib6) 1998; 9 Fontova, Colom, Rigo-Bonnin, Bestard, Vidal-Alabró, van Merendonk (bib23) 2021 Staatz, Tett (bib9) 2007; 46 Zundler, Becker, Schulze, Neurath (bib45) 2019 Sep; 68 Ramamoorthy, Cidlowski (bib4) 2016; 42 Klein, Lammens, Schäfer, Georges, Schwaiger, Mössner (bib42) 2013 Jan; 5 Ojo, Held, Port, Wolfe, Leichtman, Young (bib19) 2003 Sep 4; 349 Rodríguez-Reimundes, Buron, Chauvet, Daoud, Thaunat, Brunet (bib32) 2013 Jan; 28 Shahmohammadi, Sahraian, Shahmohammadi, Doosti, Zare-Mirzaie, Naser Moghadasi (bib40) 2018; 22 Boldizsar, Talaber, Szabo, Bartis, Palinkas, Nemeth (bib5) 2010; 215 Miroux, Moralès, Carpentier, Dharancy, Conti, Boleslowski (bib14) 2009; 41 Bak, Tischer, Dragon, Ravens, Pape, Koenecke (bib26) 2018; 9 Salas, Hernandez-Rocha, Duijvestein, Faubion, McGovern, Vermeire (bib47) 2020; 17 Mantzaris (bib11) 2017 Mar; 15 Necela, Cidlowski (bib3) 2004; 1 Kandus, Arnol, Omahen, Oblak, Vidan-Jeras, Kmetec (bib36) 2010 Apr; 89 Shi, Hesselink, van Gelder (bib13) 2015; 29 Bouvy, Klepper, Kho, Boer, Betjes, Weimar (bib30) 2014; 29 Villarroel, Hidalgo, Jimeno (bib8) 2009; 45 De Bosscher, Vanden Berghe, Haegeman (bib2) 2003; 24 Ponticelli (bib25) 2008; 21 Bhat (10.1016/j.bpg.2021.101757_bib27) 2015; 29 Jefremow (10.1016/j.bpg.2021.101757_bib46) 2020; 9 Salas (10.1016/j.bpg.2021.101757_bib47) 2020; 17 Sanford (10.1016/j.bpg.2021.101757_bib10) 2008; 68 Miroux (10.1016/j.bpg.2021.101757_bib14) 2009; 41 Naujokat (10.1016/j.bpg.2021.101757_bib31) 2007; 83 Necela (10.1016/j.bpg.2021.101757_bib3) 2004; 1 Klein (10.1016/j.bpg.2021.101757_bib42) 2013; 5 Allison (10.1016/j.bpg.2021.101757_bib7) 2000; 47 Farouk (10.1016/j.bpg.2021.101757_bib21) 2020; 27 Azzi (10.1016/j.bpg.2021.101757_bib12) 2013; 191 Han (10.1016/j.bpg.2021.101757_bib20) 2008; 28 Bouvy (10.1016/j.bpg.2021.101757_bib30) 2014; 29 Kovarik (10.1016/j.bpg.2021.101757_bib15) 1996 Leibler (10.1016/j.bpg.2021.101757_bib34) 2018; 29 Mantzaris (10.1016/j.bpg.2021.101757_bib11) 2017; 15 Waldmann (10.1016/j.bpg.2021.101757_bib37) 2002; 19 Ramamoorthy (10.1016/j.bpg.2021.101757_bib4) 2016; 42 Staatz (10.1016/j.bpg.2021.101757_bib9) 2007; 46 Villarroel (10.1016/j.bpg.2021.101757_bib8) 2009; 45 Cargill (10.1016/j.bpg.2021.101757_bib41) 2021; 12 Fontova (10.1016/j.bpg.2021.101757_bib23) 2021 Bak (10.1016/j.bpg.2021.101757_bib26) 2018; 9 Kandus (10.1016/j.bpg.2021.101757_bib36) 2010; 89 Zundler (10.1016/j.bpg.2021.101757_bib45) 2019; 68 De Bosscher (10.1016/j.bpg.2021.101757_bib2) 2003; 24 Ponticelli (10.1016/j.bpg.2021.101757_bib25) 2008; 21 Homan (10.1016/j.bpg.2021.101757_bib18) 2016; 6 Costantino (10.1016/j.bpg.2021.101757_bib44) 2008; 40 Ojo (10.1016/j.bpg.2021.101757_bib19) 2003; 349 Perez (10.1016/j.bpg.2021.101757_bib35) 2018; 102 Nielsen (10.1016/j.bpg.2021.101757_bib43) 2013; 369 Schiff (10.1016/j.bpg.2021.101757_bib16) 2007; 2 Chakkera (10.1016/j.bpg.2021.101757_bib22) 2017; 101 Ashok kumar (10.1016/j.bpg.2021.101757_bib28) 2015; 99 Rodríguez-Reimundes (10.1016/j.bpg.2021.101757_bib32) 2013; 28 Shahmohammadi (10.1016/j.bpg.2021.101757_bib40) 2018; 22 Lanese (10.1016/j.bpg.2021.101757_bib17) 1993; 91 Fantus (10.1016/j.bpg.2021.101757_bib24) 2016; 12 Anstey (10.1016/j.bpg.2021.101757_bib6) 1998; 9 Boldizsar (10.1016/j.bpg.2021.101757_bib5) 2010; 215 Shi (10.1016/j.bpg.2021.101757_bib13) 2015; 29 Dhesi (10.1016/j.bpg.2021.101757_bib38) 2009; 14 Buttgereit (10.1016/j.bpg.2021.101757_bib1) 2002; 61 Préville (10.1016/j.bpg.2021.101757_bib29) 2001; 71 Jordan (10.1016/j.bpg.2021.101757_bib33) 2011; 11 Abulayha (10.1016/j.bpg.2021.101757_bib39) 2014; 10 |
References_xml | – volume: 101 start-page: 114 year: 2017 end-page: 120 ident: bib22 article-title: Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus publication-title: Clinical Pharmacology and Therapeutics. Nature Publishing Group – volume: 19 year: 2002 ident: bib37 article-title: A personal history of the CAMPATH-1H antibody publication-title: Med Oncol – volume: 29 start-page: 224 year: 2015 end-page: 230 ident: bib13 article-title: Pharmacokinetics and pharmacodynamics of immunosuppressive drugs in elderly kidney transplant recipients publication-title: Transplantation Reviews. W.B. Saunders – volume: 14 start-page: 245 year: 2009 end-page: 249 ident: bib38 article-title: Alemtuzumab and liver transplantation: a review publication-title: Curr Opin Organ Transplant – volume: 9 start-page: 2953 year: 2018 ident: bib26 article-title: Selective effects of mTOR inhibitor Sirolimus on naïve and CMV-specific T cells extending its applicable range beyond immunosuppression publication-title: Front Immunol – volume: 17 start-page: 323 year: 2020 end-page: 337 ident: bib47 article-title: JAK–STAT pathway targeting for the treatment of inflammatory bowel disease publication-title: Nat Rev Gastroenterol Hepatol – volume: 102 start-page: 1440 year: 2018 end-page: 1452 ident: bib35 article-title: Belatacept in solid organ transplant: review of current literature across transplant types publication-title: Transplantation. Lippincott Williams and Wilkins – volume: 12 start-page: 1212 year: 2021 ident: bib41 article-title: The role of B cells and B cell therapies in immune-mediated liver diseases publication-title: Front Immunol – volume: 61 start-page: 718 year: 2002 end-page: 722 ident: bib1 article-title: Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology publication-title: Ann Rheum Dis – volume: 2 start-page: 374 year: 2007 end-page: 384 ident: bib16 article-title: Therapeutic monitoring of calcineurin inhibitors for the nephrologist publication-title: Clin J Am Soc Nephrol – volume: 9 start-page: 33 year: 1998 end-page: 47 ident: bib6 article-title: Azathioprine: clinical pharmacology and current indications in autoimmune disorders publication-title: BioDrugs – volume: 369 start-page: 754 year: 2013 Aug 22 end-page: 762 ident: bib43 article-title: Tumor necrosis factor inhibitors for inflammatory bowel disease publication-title: N Engl J Med – volume: 91 start-page: 2144 year: 1993 end-page: 2149 ident: bib17 article-title: Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles publication-title: J Clin Invest – volume: 24 start-page: 488 year: 2003 end-page: 522 ident: bib2 article-title: The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression publication-title: Endocr Rev – year: 2021 ident: bib23 article-title: Sustained inhibition of calcineurin activity with a melt-dose once-daily tacrolimus formulation in renal transplant recipients publication-title: Clin Pharmacol Ther – volume: 83 start-page: 485 year: 2007 Feb end-page: 497 ident: bib31 article-title: Antithymocyte globulins suppress dendritic cell function by multiple mechanisms publication-title: Transplantation – volume: 5 start-page: 22 year: 2013 Jan end-page: 33 ident: bib42 article-title: Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties publication-title: mAbs – volume: 41 start-page: 3371 year: 2009 end-page: 3374 ident: bib14 article-title: Inhibitory effects of cyclosporine on human regulatory T cells in vitro publication-title: Transplant Proc – volume: 191 start-page: 5785 year: 2013 Dec 15 end-page: 5791 ident: bib12 article-title: Calcineurin inhibitors: 40 Years Later, can't live without publication-title: J Immunol – volume: 22 start-page: 22 year: 2018 end-page: 26 ident: bib40 article-title: A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review publication-title: Multiple Sclerosis and Related Disorders – volume: 29 start-page: 654 year: 2015 Jul 1 end-page: 663 ident: bib27 article-title: Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk? publication-title: Clin Transplant – volume: 9 start-page: 289 year: 2020 Nov end-page: 297 ident: bib46 article-title: All are equal, some are more equal: targeting IL 12 and 23 in ibd – a clinical perspective publication-title: ImmunoTargets Ther – volume: 28 start-page: 707 year: 2008 Sep end-page: 714 ident: bib20 article-title: Prolonged endoplasmic reticulum stress induces apoptotic cell death in an experimental model of chronic cyclosporine nephropathy publication-title: Am J Nephrol – volume: 1 start-page: 239 year: 2004 end-page: 246 ident: bib3 article-title: Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells publication-title: Proc Am Thorac Soc – volume: 42 start-page: 15 year: 2016 end-page: 31 ident: bib4 article-title: Corticosteroids. Mechanisms of action in health and disease publication-title: Rheumatic Disease Clinics of North America. W.B. Saunders – volume: 28 start-page: 6 year: 2013 Jan end-page: 8 ident: bib32 article-title: Retreatment by antithymocyte globulin for second kidney transplantation: Efficacy, tolerance and safety publication-title: Transpl Immunol – volume: 40 start-page: 74 year: 2008 Jan end-page: 77 ident: bib44 article-title: Treatment of life-threatening type I refractory coeliac disease with long-term infliximab publication-title: Dig Liver Dis – volume: 68 start-page: 2505 year: 2008 end-page: 2533 ident: bib10 article-title: Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection publication-title: Drugs – volume: 71 start-page: 460 year: 2001 Feb 15 end-page: 468 ident: bib29 article-title: Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model publication-title: Transplantation – volume: 15 start-page: 84 year: 2017 Mar end-page: 104 ident: bib11 article-title: Thiopurines and methotrexate use in IBD patients in a biologic Era publication-title: Curr Treat Options Gastroenterol – volume: 68 start-page: 1688 year: 2019 Sep end-page: 1700 ident: bib45 article-title: Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances publication-title: Gut – volume: 29 start-page: 1049 year: 2018 Mar 10 end-page: 1062 ident: bib34 article-title: Control of humoral response in renal transplantation by Belatacept depends on a direct effect on B cells and impaired T follicular helper-B cell crosstalk publication-title: J Am Soc Nephrol – volume: 45 start-page: 521 year: 2009 end-page: 532 ident: bib8 article-title: Mycophenolate mofetil: an update publication-title: Drugs Today – volume: 89 start-page: 1022 year: 2010 Apr end-page: 1027 ident: bib36 article-title: Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: a prospective, randomized study publication-title: Transplantation – volume: 47 start-page: 85 year: 2000 end-page: 118 ident: bib7 article-title: Mycophenolate mofetil and its mechanisms of action publication-title: Immunopharmacology – volume: 215 start-page: 521 year: 2010 end-page: 526 ident: bib5 article-title: Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells publication-title: Immunobiology. Urban & Fischer – volume: 6 start-page: 1 year: 2016 Oct 11 end-page: 13 ident: bib18 article-title: Bioprinting of 3D convoluted renal proximal tubules on perfusable chips publication-title: Sci Rep – volume: 29 start-page: 1587 year: 2014 end-page: 1597 ident: bib30 article-title: The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients publication-title: Nephrol Dial Transplant – start-page: 429 year: 1996 end-page: 434 ident: bib15 article-title: Clinical development of a cyclosporine microemulsion in transplantation publication-title: Therapeutic drug monitoring. Ther drug monit – volume: 27 start-page: 56 year: 2020 Jan 1 end-page: 66 ident: bib21 article-title: The many faces of calcineurin inhibitor toxicity—what the FK? publication-title: Adv Chron Kidney Dis – volume: 12 start-page: 587 year: 2016 end-page: 609 ident: bib24 article-title: Roles of mTOR complexes in the kidney: implications for renal disease and transplantation publication-title: Nature Reviews Nephrology. Nature Publishing Group – volume: 99 start-page: 164 year: 2015 Jan 15 end-page: 170 ident: bib28 article-title: Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes publication-title: Transplantation – volume: 46 start-page: 13 year: 2007 end-page: 58 ident: bib9 article-title: Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients publication-title: Clin Pharmacokinet – volume: 11 start-page: 196 year: 2011 end-page: 202 ident: bib33 article-title: Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients publication-title: American Journal of Transplantation. Am J Transplant; – volume: 349 start-page: 931 year: 2003 Sep 4 end-page: 940 ident: bib19 article-title: Chronic renal failure after transplantation of a nonrenal organ publication-title: N Engl J Med – volume: 10 start-page: 2481 year: 2014 end-page: 2492 ident: bib39 article-title: Rituximab: modes of action, remaining dispute and future perspective publication-title: Future Oncol – volume: 21 start-page: 2 year: 2008 end-page: 10 ident: bib25 article-title: Can mTOR inhibitors reduce the risk of late kidney allograft failure? publication-title: Transpl Int – volume: 42 start-page: 15 year: 2016 ident: 10.1016/j.bpg.2021.101757_bib4 article-title: Corticosteroids. Mechanisms of action in health and disease publication-title: Rheumatic Disease Clinics of North America. W.B. Saunders doi: 10.1016/j.rdc.2015.08.002 – volume: 21 start-page: 2 year: 2008 ident: 10.1016/j.bpg.2021.101757_bib25 article-title: Can mTOR inhibitors reduce the risk of late kidney allograft failure? publication-title: Transpl Int – volume: 22 start-page: 22 year: 2018 ident: 10.1016/j.bpg.2021.101757_bib40 article-title: A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review publication-title: Multiple Sclerosis and Related Disorders doi: 10.1016/j.msard.2018.02.030 – volume: 40 start-page: 74 issue: 1 year: 2008 ident: 10.1016/j.bpg.2021.101757_bib44 article-title: Treatment of life-threatening type I refractory coeliac disease with long-term infliximab publication-title: Dig Liver Dis doi: 10.1016/j.dld.2006.10.017 – volume: 29 start-page: 1049 issue: 3 year: 2018 ident: 10.1016/j.bpg.2021.101757_bib34 article-title: Control of humoral response in renal transplantation by Belatacept depends on a direct effect on B cells and impaired T follicular helper-B cell crosstalk publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2017060679 – volume: 369 start-page: 754 issue: 8 year: 2013 ident: 10.1016/j.bpg.2021.101757_bib43 article-title: Tumor necrosis factor inhibitors for inflammatory bowel disease publication-title: N Engl J Med doi: 10.1056/NEJMct1209614 – volume: 2 start-page: 374 year: 2007 ident: 10.1016/j.bpg.2021.101757_bib16 article-title: Therapeutic monitoring of calcineurin inhibitors for the nephrologist publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.03791106 – volume: 45 start-page: 521 year: 2009 ident: 10.1016/j.bpg.2021.101757_bib8 article-title: Mycophenolate mofetil: an update publication-title: Drugs Today doi: 10.1358/dot.2009.45.7.1384878 – year: 2021 ident: 10.1016/j.bpg.2021.101757_bib23 article-title: Sustained inhibition of calcineurin activity with a melt-dose once-daily tacrolimus formulation in renal transplant recipients publication-title: Clin Pharmacol Ther doi: 10.1002/cpt.2220 – volume: 12 start-page: 587 year: 2016 ident: 10.1016/j.bpg.2021.101757_bib24 article-title: Roles of mTOR complexes in the kidney: implications for renal disease and transplantation publication-title: Nature Reviews Nephrology. Nature Publishing Group doi: 10.1038/nrneph.2016.108 – volume: 89 start-page: 1022 issue: 8 year: 2010 ident: 10.1016/j.bpg.2021.101757_bib36 article-title: Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: a prospective, randomized study publication-title: Transplantation doi: 10.1097/TP.0b013e3181d02496 – volume: 83 start-page: 485 issue: 4 year: 2007 ident: 10.1016/j.bpg.2021.101757_bib31 article-title: Antithymocyte globulins suppress dendritic cell function by multiple mechanisms publication-title: Transplantation doi: 10.1097/01.tp.0000251975.81281.22 – volume: 19 year: 2002 ident: 10.1016/j.bpg.2021.101757_bib37 article-title: A personal history of the CAMPATH-1H antibody publication-title: Med Oncol doi: 10.1385/MO:19:2S:S03 – volume: 9 start-page: 2953 year: 2018 ident: 10.1016/j.bpg.2021.101757_bib26 article-title: Selective effects of mTOR inhibitor Sirolimus on naïve and CMV-specific T cells extending its applicable range beyond immunosuppression publication-title: Front Immunol doi: 10.3389/fimmu.2018.02953 – volume: 17 start-page: 323 year: 2020 ident: 10.1016/j.bpg.2021.101757_bib47 article-title: JAK–STAT pathway targeting for the treatment of inflammatory bowel disease publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-020-0273-0 – volume: 68 start-page: 2505 year: 2008 ident: 10.1016/j.bpg.2021.101757_bib10 article-title: Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection publication-title: Drugs doi: 10.2165/0003495-200868170-00007 – volume: 101 start-page: 114 year: 2017 ident: 10.1016/j.bpg.2021.101757_bib22 article-title: Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus publication-title: Clinical Pharmacology and Therapeutics. Nature Publishing Group doi: 10.1002/cpt.546 – volume: 102 start-page: 1440 year: 2018 ident: 10.1016/j.bpg.2021.101757_bib35 article-title: Belatacept in solid organ transplant: review of current literature across transplant types publication-title: Transplantation. Lippincott Williams and Wilkins – volume: 15 start-page: 84 issue: 1 year: 2017 ident: 10.1016/j.bpg.2021.101757_bib11 article-title: Thiopurines and methotrexate use in IBD patients in a biologic Era publication-title: Curr Treat Options Gastroenterol doi: 10.1007/s11938-017-0128-0 – volume: 29 start-page: 224 year: 2015 ident: 10.1016/j.bpg.2021.101757_bib13 article-title: Pharmacokinetics and pharmacodynamics of immunosuppressive drugs in elderly kidney transplant recipients publication-title: Transplantation Reviews. W.B. Saunders doi: 10.1016/j.trre.2015.04.007 – volume: 61 start-page: 718 issue: 8 year: 2002 ident: 10.1016/j.bpg.2021.101757_bib1 article-title: Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology publication-title: Ann Rheum Dis doi: 10.1136/ard.61.8.718 – volume: 6 start-page: 1 issue: 1 year: 2016 ident: 10.1016/j.bpg.2021.101757_bib18 article-title: Bioprinting of 3D convoluted renal proximal tubules on perfusable chips publication-title: Sci Rep doi: 10.1038/srep34845 – volume: 29 start-page: 654 issue: 7 year: 2015 ident: 10.1016/j.bpg.2021.101757_bib27 article-title: Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk? publication-title: Clin Transplant doi: 10.1111/ctr.12559 – volume: 10 start-page: 2481 year: 2014 ident: 10.1016/j.bpg.2021.101757_bib39 article-title: Rituximab: modes of action, remaining dispute and future perspective publication-title: Future Oncol doi: 10.2217/fon.14.146 – volume: 14 start-page: 245 year: 2009 ident: 10.1016/j.bpg.2021.101757_bib38 article-title: Alemtuzumab and liver transplantation: a review publication-title: Curr Opin Organ Transplant doi: 10.1097/MOT.0b013e32832b45d0 – volume: 5 start-page: 22 issue: 1 year: 2013 ident: 10.1016/j.bpg.2021.101757_bib42 article-title: Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties publication-title: mAbs doi: 10.4161/mabs.22771 – volume: 71 start-page: 460 issue: 3 year: 2001 ident: 10.1016/j.bpg.2021.101757_bib29 article-title: Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model publication-title: Transplantation doi: 10.1097/00007890-200102150-00021 – volume: 41 start-page: 3371 issue: 8 year: 2009 ident: 10.1016/j.bpg.2021.101757_bib14 article-title: Inhibitory effects of cyclosporine on human regulatory T cells in vitro publication-title: Transplant Proc doi: 10.1016/j.transproceed.2009.08.043 – volume: 46 start-page: 13 year: 2007 ident: 10.1016/j.bpg.2021.101757_bib9 article-title: Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients publication-title: Clin Pharmacokinet doi: 10.2165/00003088-200746010-00002 – volume: 191 start-page: 5785 issue: 12 year: 2013 ident: 10.1016/j.bpg.2021.101757_bib12 article-title: Calcineurin inhibitors: 40 Years Later, can't live without publication-title: J Immunol doi: 10.4049/jimmunol.1390055 – volume: 28 start-page: 6 issue: 1 year: 2013 ident: 10.1016/j.bpg.2021.101757_bib32 article-title: Retreatment by antithymocyte globulin for second kidney transplantation: Efficacy, tolerance and safety publication-title: Transpl Immunol doi: 10.1016/j.trim.2012.11.008 – volume: 1 start-page: 239 year: 2004 ident: 10.1016/j.bpg.2021.101757_bib3 article-title: Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells publication-title: Proc Am Thorac Soc doi: 10.1513/pats.200402-005MS – start-page: 429 year: 1996 ident: 10.1016/j.bpg.2021.101757_bib15 article-title: Clinical development of a cyclosporine microemulsion in transplantation – volume: 27 start-page: 56 issue: 1 year: 2020 ident: 10.1016/j.bpg.2021.101757_bib21 article-title: The many faces of calcineurin inhibitor toxicity—what the FK? publication-title: Adv Chron Kidney Dis doi: 10.1053/j.ackd.2019.08.006 – volume: 12 start-page: 1212 year: 2021 ident: 10.1016/j.bpg.2021.101757_bib41 article-title: The role of B cells and B cell therapies in immune-mediated liver diseases publication-title: Front Immunol doi: 10.3389/fimmu.2021.661196 – volume: 9 start-page: 289 year: 2020 ident: 10.1016/j.bpg.2021.101757_bib46 article-title: All are equal, some are more equal: targeting IL 12 and 23 in ibd – a clinical perspective publication-title: ImmunoTargets Ther doi: 10.2147/ITT.S282466 – volume: 29 start-page: 1587 issue: 8 year: 2014 ident: 10.1016/j.bpg.2021.101757_bib30 article-title: The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfu079 – volume: 9 start-page: 33 year: 1998 ident: 10.1016/j.bpg.2021.101757_bib6 article-title: Azathioprine: clinical pharmacology and current indications in autoimmune disorders publication-title: BioDrugs doi: 10.2165/00063030-199809010-00004 – volume: 215 start-page: 521 year: 2010 ident: 10.1016/j.bpg.2021.101757_bib5 article-title: Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells publication-title: Immunobiology. Urban & Fischer doi: 10.1016/j.imbio.2009.10.003 – volume: 68 start-page: 1688 issue: 9 year: 2019 ident: 10.1016/j.bpg.2021.101757_bib45 article-title: Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances publication-title: Gut doi: 10.1136/gutjnl-2018-317977 – volume: 349 start-page: 931 issue: 10 year: 2003 ident: 10.1016/j.bpg.2021.101757_bib19 article-title: Chronic renal failure after transplantation of a nonrenal organ publication-title: N Engl J Med doi: 10.1056/NEJMoa021744 – volume: 91 start-page: 2144 issue: 5 year: 1993 ident: 10.1016/j.bpg.2021.101757_bib17 article-title: Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles publication-title: J Clin Invest doi: 10.1172/JCI116440 – volume: 99 start-page: 164 issue: 1 year: 2015 ident: 10.1016/j.bpg.2021.101757_bib28 article-title: Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes publication-title: Transplantation doi: 10.1097/TP.0000000000000289 – volume: 47 start-page: 85 issue: 2–3 year: 2000 ident: 10.1016/j.bpg.2021.101757_bib7 article-title: Mycophenolate mofetil and its mechanisms of action publication-title: Immunopharmacology doi: 10.1016/S0162-3109(00)00188-0 – volume: 28 start-page: 707 issue: 5 year: 2008 ident: 10.1016/j.bpg.2021.101757_bib20 article-title: Prolonged endoplasmic reticulum stress induces apoptotic cell death in an experimental model of chronic cyclosporine nephropathy publication-title: Am J Nephrol doi: 10.1159/000127432 – volume: 11 start-page: 196 year: 2011 ident: 10.1016/j.bpg.2021.101757_bib33 article-title: Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients publication-title: American Journal of Transplantation. Am J Transplant; doi: 10.1111/j.1600-6143.2010.03400.x – volume: 24 start-page: 488 year: 2003 ident: 10.1016/j.bpg.2021.101757_bib2 article-title: The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression publication-title: Endocr Rev doi: 10.1210/er.2002-0006 |
SSID | ssj0001699 |
Score | 2.4667926 |
SecondaryResourceType | review_article |
Snippet | The innate and adaptive immune systems work as a complex interplay between different cell types, involving cytokines and chemokines mediating extracellular and... |
SourceID | proquest crossref elsevier |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 101757 |
SubjectTerms | Acids Allotransplantation Autoimmune diseases Autoimmunity Binding sites Bioavailability Cell cycle Clinical medicine Cytokines Dihydrofolate reductase Drug dosages Enzymes Gene expression Immunosuppression Immunosuppressive agents Kinases Metabolism Metabolites Pharmacokinetics Proteins Steroids Transcription factors Transplants & implants |
Title | Immunosuppressive drugs modes of action |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1521691821000378 https://dx.doi.org/10.1016/j.bpg.2021.101757 https://www.proquest.com/docview/2607316199 https://www.proquest.com/docview/2608131722 |
Volume | 54-55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA5jgvgiXnE6RwVBEOqaS7PmcQzH5tge1OHeQpJ2YyLr2MVHf7snaTtRZIJPvZ2TNqfJOV_IuSB0HQqqOTPKb_CA-syQ2FeBIL7hAuACrHy4S_bcH_DOkD2MwlEJtYpYGOtWmev-TKc7bZ3fqefSrM-n0_qTtTzQYkSwy6JiA35t9joY03cfX24eQCJczlSCfUtd7Gw6Hy89n8ASkWCXbchaqN9t0w8t7UxP-wDt55jRa2afdYhKyewI7fbzXfFjdNO1QR7pcj3PvFrfEy9erCdLz5a5WXrp2MuiF07QsH3_3Or4eQEE37AQr3xNgjhiuJFgFitDI-iDwkbFVAlQcGbMohjAsabcAKrQYJiZxoI1NE5Iw1AT0lNUnqWz5Ax5IuJaBEzFLAIARFnEmVBwxsMxQJiYVlBQdF2aPDu4LVLxJgs3sFcJ0pJWWjKTVgXdbljmWWqMbcSkkKcsYj5BS0lQ3NuY2Ibp26D4i61a_DCZz8ilhHWbLdKFhaigq81jmEt2g0TNknTtaCIMgIqQ8_-9-QLt2avM2a-KyqvFOrkE0LLSNTcqa2in2e11BvbYe3zpfQK3lOcW |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD7oBPVFvOK8VhAEoay5NEseZSibur24wd5CknaiyDbc5u_3pE0Hiij4VpqctjlNvvOFnAvAZaqYFdyZuCkSFnNHs9gkisZOKKQLuPMRRbLnbk-0B_x-mA5XoFXFwni3yoD9JaYXaB3uNII2G9OXl8aTtzz4RElJkUVFrsKaz07Fa7B203lo95aAjL1UkTaVktgLVIebhZuXnT7jLpGSIuGQN1I_m6dvQF1Yn7tt2Aq0Mbopv2wHVvLxLqx3w8H4Hlx1fJzHZLaYlo6tH3mUvS-eZ5GvdDOLJqOoDGDYh8Hdbb_VjkMNhNjxlMxjS5NMctLMCc-MYxLHYIgzGTMKMc6NuMyQH1smHBILi7aZW6J405KcNh1zKTuA2ngyzg8hUlJYlXCTcYkciHEpuDJ4JdIRspiM1SGphq5dSBDu61S86coT7FWjtrTXli61VYfrpci0zI7xW2da6VNXYZ8IVBqx-zchvhT6Mi_-EjupfpgOi3Kmcevm63QRpepwsWzG5eTPSMw4nyyKPpIgp6L06H9vPoeNdr_7qB87vYdj2PQtpe_fCdTm74v8FDnM3J6FOfoJdl7oJA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunosuppressive+drugs+modes+of+action&rft.jtitle=Bailli%C3%A8re%27s+best+practice+%26+research.+Clinical+gastroenterology&rft.au=Meneghini%2C+Maria&rft.au=Bestard%2C+Oriol&rft.au=Grinyo%2C+Josep+Maria&rft.date=2021-10-01&rft.issn=1532-1916&rft.eissn=1532-1916&rft.volume=54-55&rft.spage=101757&rft_id=info:doi/10.1016%2Fj.bpg.2021.101757&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1521-6918&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1521-6918&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1521-6918&client=summon |